BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23063511)

  • 1. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
    Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
    Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts.
    Ravanko K; Järvinen K; Helin J; Kalkkinen N; Hölttä E
    Cancer Res; 2004 Dec; 64(24):8831-8. PubMed ID: 15604241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.
    Tulley S; Chen WT
    J Biol Chem; 2014 May; 289(22):15280-96. PubMed ID: 24727589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-β1-FAP-α.
    Wäster P; Orfanidis K; Eriksson I; Rosdahl I; Seifert O; Öllinger K
    Br J Cancer; 2017 Aug; 117(4):535-544. PubMed ID: 28697174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of cathepsin B in fibroblasts isolated from primary melanoma in comparison to fibroblasts from normal skin.
    Ulmer A; Körber V; Schmid H; Fierlbeck G
    Exp Dermatol; 1998 Feb; 7(1):14-7. PubMed ID: 9517917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.
    Fröhlich E; Schlagenhauff B; Möhrle M; Weber E; Klessen C; Rassner G
    Cancer; 2001 Mar; 91(5):972-82. PubMed ID: 11251949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts.
    Yamaguchi T; Naruishi K; Arai H; Nishimura F; Takashiba S
    J Cell Physiol; 2008 Nov; 217(2):423-32. PubMed ID: 18543249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.
    Tripathi R; Fiore LS; Richards DL; Yang Y; Liu J; Wang C; Plattner R
    Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
    Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
    Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours.
    Kageshita T; Yoshii A; Kimura T; Maruo K; Ono T; Himeno M; Nishimura Y
    Arch Dermatol Res; 1995; 287(3-4):266-72. PubMed ID: 7598531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
    Gerber A; Wille A; Welte T; Ansorge S; Bühling F
    J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
    Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
    Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R; Casey SF
    Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
    Fröhlich E; Möhrle M; Klessen C
    Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin K in melanoma invasion.
    Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
    J Invest Dermatol; 2008 Sep; 128(9):2281-8. PubMed ID: 18368130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.